Scan-directed unilateral neck exploration for primary hyperparathyroidism: eight-year results from a regional hospital

Hong Kong Med J. 2009 Apr;15(2):118-21.

Abstract

Objective: To determine the results of scan-directed unilateral neck exploration for primary hyperparathyroidism.

Design: Retrospective study.

Setting: Regional hospital, Hong Kong.

Patients: Patients who underwent parathyroid surgery for primary hyperparathyroidism between January 2000 and December 2007 were included.

Main outcome measures: The demographic, imaging, biochemical, and pathological data, as well as surgical outcomes were analysed according to the treatment received.

Results: A total of 78 patients were included in this study; 65 underwent unilateral neck exploration with image guidance by ultrasonography or technetium Tc99m sestamibi scan. The scan sensitivity for localising the side of the lesion was 66% for ultrasound scans, 71% for technetium Tc99m sestamibi scans, and 85% for both scans used in combination. Pathological analysis showed that 95% (74/78) of the patients had a single parathyroid adenoma, two had hyperplasia of four glands, one had a double adenoma, and one a parathyroid carcinoma. Among the patients undergoing scan-directed unilateral neck exploration, one defaulted follow-up, while the remaining 64 patients achieved normal calcium levels at a median follow-up of 6 months.

Conclusion: Scan-directed unilateral neck exploration is a safe alternative form of treatment for patients with primary hyperparathyroidism, with a cure rate similar to conventional therapy.

Publication types

  • Comparative Study

MeSH terms

  • Adenoma / diagnosis
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma / diagnosis
  • Female
  • Humans
  • Hyperparathyroidism, Primary / diagnosis*
  • Hyperparathyroidism, Primary / surgery*
  • Hyperplasia
  • Male
  • Middle Aged
  • Neck / diagnostic imaging*
  • Parathyroid Neoplasms / diagnosis
  • Radionuclide Imaging
  • Retrospective Studies
  • Sensitivity and Specificity
  • Technetium Tc 99m Sestamibi
  • Ultrasonography

Substances

  • Technetium Tc 99m Sestamibi